These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 22020739

  • 21. The efficacy of chemotherapy in patients with high-grade metastatic colon cancer.
    Liu CJ, Lin JK, Chen WS, Lin TC, Yang SH, Jiang JK, Chang SC, Lan YT, Yen CC, Tzeng CH, Wang HW, Teng HW.
    Hepatogastroenterology; 2011; 58(110-111):1495-501. PubMed ID: 21940314
    [Abstract] [Full Text] [Related]

  • 22. The cost-effectiveness of different chemotherapy strategies for patients with poor prognosis advanced colorectal cancer (MRC FOCUS).
    Manca A, Asseburg C, Bravo Vergel Y, Seymour MT, Meade A, Stephens R, Parmar M, Sculpher MJ.
    Value Health; 2012 Jan; 15(1):22-31. PubMed ID: 22264968
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial.
    Tournigand C, André T, Bonnetain F, Chibaudel B, Lledo G, Hickish T, Tabernero J, Boni C, Bachet JB, Teixeira L, de Gramont A.
    J Clin Oncol; 2012 Sep 20; 30(27):3353-60. PubMed ID: 22915656
    [Abstract] [Full Text] [Related]

  • 25. CDX2 Biomarker Testing and Adjuvant Therapy for Stage II Colon Cancer: An Exploratory Cost-Effectiveness Analysis.
    Alarid-Escudero F, Schrag D, Kuntz KM.
    Value Health; 2022 Mar 20; 25(3):409-418. PubMed ID: 35227453
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cost-effectiveness analysis of bevacizumab combined with chemotherapy for the treatment of metastatic colorectal cancer in Japan.
    Shiroiwa T, Fukuda T, Tsutani K.
    Clin Ther; 2007 Oct 20; 29(10):2256-67. PubMed ID: 18042483
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Cost-utility analysis of adjuvant chemotherapy in patients with stage III colon cancer in Thailand.
    Lerdkiattikorn P, Chaikledkaew U, Lausoontornsiri W, Chindavijak S, Khuhaprema T, Tantai N, Teerawattananon Y.
    Expert Rev Pharmacoecon Outcomes Res; 2015 Oct 20; 15(4):687-700. PubMed ID: 25327502
    [Abstract] [Full Text] [Related]

  • 33. Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest.
    Falcone A, Ricci S, Brunetti I, Pfanner E, Allegrini G, Barbara C, Crinò L, Benedetti G, Evangelista W, Fanchini L, Cortesi E, Picone V, Vitello S, Chiara S, Granetto C, Porcile G, Fioretto L, Orlandini C, Andreuccetti M, Masi G, Gruppo Oncologico Nord Ovest.
    J Clin Oncol; 2007 May 01; 25(13):1670-6. PubMed ID: 17470860
    [Abstract] [Full Text] [Related]

  • 34. Cost effectiveness of adding folinic acid to fluorouracil plus levamisole as adjuvant chemotherapy in patients with colon cancer in Germany.
    Monz BU, König HH, Leidl R, Staib L, Link KH.
    Pharmacoeconomics; 2003 May 01; 21(10):709-19. PubMed ID: 12828493
    [Abstract] [Full Text] [Related]

  • 35. Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer.
    Fischer von Weikersthal L, Schalhorn A, Stauch M, Quietzsch D, Maubach PA, Lambertz H, Oruzio D, Schlag R, Weigang-Köhler K, Vehling-Kaiser U, Schulze M, Truckenbrodt J, Goebeler M, Mittermüller J, Bosse D, Szukics B, Grundeis M, Zwingers T, Giessen C, Heinemann V.
    Eur J Cancer; 2011 Jan 01; 47(2):206-14. PubMed ID: 20971632
    [Abstract] [Full Text] [Related]

  • 36. Cost-Effectiveness Analysis of Adjuvant Stage III Colon Cancer Treatment at Veterans Affairs Medical Centers.
    Soni A, Aspinall SL, Zhao X, Good CB, Cunningham FE, Chatta G, Passero V, Smith KJ.
    Oncol Res; 2014 Jan 01; 22(5-6):311-9. PubMed ID: 26629943
    [Abstract] [Full Text] [Related]

  • 37. Cost-effectiveness of Capecitabine + Irinotecan Versus Leucovorin + Fluorouracil + Irinotecan in the Second-line Treatment of Metastatic Colorectal Cancer in China.
    Wu Q, Zhang P, Wang X, Zhang M, Liao W, Li Q.
    Clin Ther; 2020 Nov 01; 42(11):2148-2158.e2. PubMed ID: 32981743
    [Abstract] [Full Text] [Related]

  • 38. Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.
    Asseburg C, Frank M, Köhne CH, Hartmann JT, Griebsch I, Mohr A, Osowski U, Schulten J, Mittendorf T.
    Clin Ther; 2011 Apr 01; 33(4):482-97. PubMed ID: 21635994
    [Abstract] [Full Text] [Related]

  • 39. Cost-effectiveness analysis of cetuximab combined with chemotherapy as a first-line treatment for patients with RAS wild-type metastatic colorectal cancer based on the TAILOR trial.
    Wang H, Huang L, Gao P, Zhu Z, Ye W, Ding H, Fang L.
    BMJ Open; 2020 Feb 12; 10(2):e030738. PubMed ID: 32051297
    [Abstract] [Full Text] [Related]

  • 40. Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.
    Van Cutsem E, Labianca R, Bodoky G, Barone C, Aranda E, Nordlinger B, Topham C, Tabernero J, André T, Sobrero AF, Mini E, Greil R, Di Costanzo F, Collette L, Cisar L, Zhang X, Khayat D, Bokemeyer C, Roth AD, Cunningham D.
    J Clin Oncol; 2009 Jul 01; 27(19):3117-25. PubMed ID: 19451425
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.